INmune Bio Advances CORDStrom™ Platform Patent Application in the U.S. Following Favorable International Written Opinion

Go back to INmune Bio Advances CORDStrom™ Platform Patent Application in the U.S. Following Favorable International Written Opinion
(NASDAQ: INMB) Delayed: 2.44 +0.17 (7.49%)
Previous Close $2.27    52 Week High
Open $2.27    52 Week Low
Day High $2.45    P/E N/A 
Day Low $2.22    EPS
Volume 323,962       

(NASDAQ: INMB) Delayed: 2.44 +0.17 (7.49%)
Previous Close $2.27    52 Week High
Open $2.27    52 Week Low
Day High $2.45    P/E N/A 
Day Low $2.22    EPS
Volume 323,962